Our markets are growing rapidly, particularly in the tachycardia (+ 20 % per year), diagnosis, heart failure and remote monitoring areas. We have a strong hold on Europe, with market shares exceeding 20 % in Italy and France. Our highest growth rates can be found in the US market which increased over 50 % in 2005. In the demanding Asian market, our products are also very well known especially for their innovative and reliable characteristics.

Our leaders have many years of experience with large international groups, bringing with them the vision which drives the growth we are currently experiencing. Due to our moderate size and European background, we feel different from our competitors.

Sorin Group headquarters and Business Units are all based in Europe however we offer unique opportunities to colleagues wishing to be expatriated to the USA or Canada (we have about 900 employees based in North America).

Print this page